Study guide

6.2 Neonatal and Paediatric Physiological Differences

EDAIC Part I European Diploma in Anaesthesiology and Intensive Care

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The EDAIC Part I Examination

1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy

2 Chapter 2: Anatomy for Anaesthesia and Intensive Care

2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart

3 Chapter 3: Respiratory and Cardiovascular Physiology

3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics

4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology

4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach

5 Chapter 5: Endocrine and Haematological Physiology

5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders

6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric

6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation

7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics

7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity

8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics

8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents

9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics

9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy

10 Chapter 10: Haematological and Internal Medicine Pharmacology

10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions

11 Chapter 11: Physics, Clinical Measurement and Medical Equipment

11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring

12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis

12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units

13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal

13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)

14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management

14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting

15 Chapter 15: Coexisting Disease and Preoperative Investigations

15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease

16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia

16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury

17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia

17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia

18 Chapter 18: Anaesthetic Complications and Specialty Settings

18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery

19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management

19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management

20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support

20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination

21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes

21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate

22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies

22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure

23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics

23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration

24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies

24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy

25 Chapter 25: Burns, Environmental Emergencies and Patient Transport

25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill

6.2 Neonatal and Paediatric Physiological Differences

Key Takeaways Explain This Topic AI

The neonatal myocardium is non-compliant with only ~30% contractile elements and near-maximal resting contractility, making stroke volume relatively fixed and cardiac output strictly dependent on heart rate.

The neonatal airway is characterized by a cephalad larynx (C3-C4), large occiput causing neck flexion, large tongue, omega-shaped epiglottis, and a funnel-shaped airway with the narrowest rigid diameter at the cricoid ring.

A high alveolar ventilation-to-FRC ratio ( V A / FRC ≈ 5 : 1 V_A/\text{FRC} \approx 5:1 V A ​ / FRC ≈ 5 : 1 ) combined with high resting O 2 \text{O}_2 O 2 ​ consumption (6-8 mL/kg/min) drives both rapid inhalational washin/emergence and precipitous, catastrophic desaturation during hypoventilation.

Total body water accounts for 75-80% of body weight in neonates with extracellular fluid volume at 40%, necessitating higher weight-based loading doses of water-soluble drugs such as succinylcholine.

Neonatal diaphragmatic muscle contains only 10-25% Type I slow-twitch oxidative fibers (versus 50-55% in adults), predisposing infants to early diaphragmatic fatigue, paradoxical chest wall collapse, and hypoventilatory respiratory failure under increased respiratory workloads.

Last updated: October 2026

6.2 Neonatal and Paediatric Physiological Differences

Paediatric patients—especially neonates (first 28 days of life) and infants (up to 1 year)—exhibit distinct anatomical configurations and immature physiological organ systems. Treating them as scaled-down adults is a dangerous pitfall in anaesthesia. Clinical success requires an intimate understanding of immature myocardial dynamics, transitional circulation pathways, high oxygen consumption, airway geometry, and developmental pharmacokinetics.

  • 1. Cardiovascular Dynamics and Transitional Circulation
  • Myocardial Architecture and Contractility

Contractile vs Non-Contractile Tissue: The neonatal myocardium is structurally immature. Only 30% of myocardial mass consists of contractile myofibrils, compared to 60% in the adult heart; the remaining 70% is composed of non-contractile connective tissue, interstitial fluid, and cellular organelles. The myofibrils are arranged in a disorganized, random lattice rather than parallel aligned sarcomeres.

Sarcoplasmic Reticulum Incompetence: The neonatal sarcoplasmic reticulum and transverse tubule (T-tubule) network are poorly developed. Consequently, the neonatal myocyte has limited intracellular calcium storage and cannot mobilize large internal calcium bursts during excitation-contraction coupling. Neonatal contractility is heavily dependent on extracellular ionized calcium influx across the sarcolemma. Hypocalcaemia, citrate toxicity from rapid blood transfusion, and calcium-channel blocking drugs precipitate acute electromechanical dissociation or severe myocardial depression.

Ventricular Non-Compliance and the Frank-Starling Law: The immature left ventricle is stiff, fibrous, and non-compliant. At rest, it operates near the peak of its length-tension curve. Unlike the adult heart, the neonatal ventricle cannot distend significantly to increase stroke volume ( S V SV S V ) in response to fluid challenges. Excessive volume loading easily elevates filling pressures, precipitating pulmonary capillary leak and congestive heart failure without augmenting stroke volume.

Rate-Dependent Cardiac Output

Because stroke volume is essentially fixed by high ventricular stiffness, cardiac output ( C O CO CO ) is governed strictly by heart rate ( H R HR H R ):

C O = H R × S V CO = HR \times SV CO = H R × S V

Significance of Bradycardia: In a neonate or young infant, bradycardia (heart rate < 100 bpm < 100\text{ bpm} < 100 bpm in a neonate, < 80 bpm < 80\text{ bpm} < 80 bpm in an infant) causes a proportional, catastrophic collapse of cardiac output and systemic blood pressure.

Autonomic Tone: The neonatal autonomic nervous system displays marked parasympathetic (vagal) predominance . Sympathetic ventricular innervation is sparse and incomplete at birth, whereas vagal innervation to the sinoatrial and atrioventricular nodes is fully mature. Vagal stimuli—such as direct laryngoscopy, pharyngeal suctioning, hypoxia, or the administration of halogenated volatile anaesthetics or succinylcholine—promptly elicit profound reflex bradycardia. Premedication with an anticholinergic (atropine 10-20 mcg/kg IV/IM or glycopyrrolate 10 mcg/kg IV) is widely utilized to mitigate reflex vagal arrest. [ IMMATURE NEONATAL MYOCARDIUM ]

  • |
  • +--------------------------+--------------------------+
  • | |
  • [ Only 30% Contractile Elements ] [ Underdeveloped SR / T-Tubules ]
  • | |
  • Non-Compliant, Stiff LV Dependent on Extracellular Ca2+
  • Operates at Peak Starling Curve Extremely Sensitive to Hypocalcaemia
  • | |
  • Stroke Volume Is Fixed |
  • +--------------------------+--------------------------+
  • |
  • [ CO = HR x Fixed Stroke Volume ]
  • |
  • Cardiac Output Is Strictly Rate-Dependent
  • (Bradycardia Causes Catastrophic Hypotension)
  • The Fetal Circulation and Transitional Shunts

In utero, the placenta serves as the organ of gas exchange. Fetal pulmonary vascular resistance (PVR) is extremely high due to fluid-filled alveoli, hypoxic vasoconstriction, and a muscularized pulmonary arteriolar bed. Systemic vascular resistance (SVR) is low. Three vascular conduits route blood past non-functioning organs:

Ductus Venosus: Transports ~50% of oxygenated umbilical venous blood from the placenta directly into the inferior vena cava, bypassing the hepatic microcirculation.

Foramen Ovale: An interatrial valve that directs oxygen-rich blood entering the right atrium from the IVC across the fossa ovalis into the left atrium, left ventricle, and ascending aorta to nourish the coronary arteries and cerebral cortex.

Ductus Arteriosus: Connects the main pulmonary artery directly to the descending aorta, diverting desaturated blood ejected by the right ventricle away from the high-resistance pulmonary bed into the systemic circulation and back to the placenta.

Transitional Changes at Delivery

PVR Drop: Aeration of the lungs, expansion of alveoli, and a sharp rise in alveolar oxygen tension stimulate endogenous nitric oxide and prostacyclin production, triggering immediate pulmonary vasodilation and a precipitous fall in PVR.

SVR Surge: Clamping of the low-resistance umbilical cord doubles systemic vascular resistance.

Shunt Closures:

Left atrial pressure surpasses right atrial pressure, forcing the flexible flap of the septum primum against the rigid septum secundum, functionally closing the foramen ovale within minutes of birth.

The sudden elevation of arterial P a O 2 P_a\text{O}_2 P a ​ O 2 ​ ( > 50 mmHg > 50\text{ mmHg} > 50 mmHg ) and the elimination of placental prostaglandin E 2 E_2 E 2 ​ ( P G E 2 PGE_2 PG E 2 ​ ) induce intense muscular constriction of the ductus arteriosus (functional closure occurs within 10 to 15 hours; anatomical fibrosis into the ligamentum arteriosum is complete by 2 to 3 weeks).

The ductus venosus closes following umbilical cord cessation, fibrosing into the ligamentum venosum.

Persistent Pulmonary Hypertension of the Neonate (PPHN)

Under physiological stress during the transitional period, the muscularized pulmonary vasculature can rapidly revert to the fetal state. Noxious triggers include:

  • Hypoxia / Hypoxaemia ( P a O 2 < 60 mmHg P_a\text{O}_2 < 60\text{ mmHg} P a ​ O 2 ​ < 60 mmHg )
  • Hypercapnia / Acidosis ( p H < 7.25 pH < 7.25 p H < 7.25 )
  • Hypothermia (core temperature < 36.0 ∘ C < 36.0^\circ\text{C} < 36. 0 ∘ C )
  • Excessive Airway Pressures / High Mean Airway Pressure
  • Sepsis and Pain / Light Anaesthesia

These triggers provoke acute pulmonary arteriolar vasoconstriction, causing PVR to surge above SVR. Suprasystemic right ventricular pressures force unoxygenated blood right-to-left across a patent foramen ovale or ductus arteriosus, establishing a vicious cycle of refractory hypoxaemia, acidosis, and right ventricular failure.

2. Neonatal Respiratory Anatomy, Mechanics, and Gas Exchange

Upper Airway Differences: Neonate vs Adult ADULT AIRWAY: Cylindrical / Barrel Shape NEONATAL AIRWAY: Conical / Funnel Shape

  • ___ ___
  • / \ / \
  • | | <-- Narrowest point: / \ <-- C3-C4 Cephalad Larynx
  • | | Vocal Cords (Rima Glottidis) / \ Large Floppy Epiglottis
  • | | \ /
  • | | \ / <-- Narrowest point: Cricoid Ring
  • |_____| |___| (Rigid, Complete Cartilage)

Anatomical Feature Neonatal / Infant Airway Adult Airway Clinical Implication

Occiput Disproportionately large, prominent Flat, proportionate Passive neck flexion in supine position; requires a shoulder roll (not head elevation) to align axes.

Tongue Large relative to oral cavity and mandible Proportionate Prone to posterior pharyngeal obstruction; leaves narrow oral corridor for laryngoscope blade.

Laryngeal Position Cephalad at C3-C4 Lower at C4-C5 / C5-C6 Steeper, acute angle between tongue base and glottic opening; larynx appears anterior during laryngoscopy.

Epiglottis Long, narrow, stiff, omega-shaped ( Ω \Omega Ω ) , angled posteriorly Flat, broad, flexible Difficult to displace indirectly via the vallecula; straight Miller blade used to lift epiglottis directly.

Vocal Cords Slanted anteroinferiorly Perpendicular / horizontal Endotracheal tube tip easily catches on anterior commissure; requires slight tube rotation.

Laryngeal Contour Conical / funnel-shaped Cylindrical The cricoid cartilage represents the narrowest rigid circular cross-section of the upper airway.

Tracheal Length Short (~4 cm in neonates, ~5 cm in infants) Long (10-15 cm) Small margin of safety; slight head flexion advances tube into right bronchus; extension causes extubation.

Cricoid Geometry and Airway Resistance

In the infant, the conical tapering of the subglottic airway renders the complete cartilaginous cricoid ring the narrowest anatomical constriction. Airway resistance to laminar flow is governed by Poiseuille's equation:

R = 8 η L π r 4 R = \frac{8\eta L}{\pi r^4} R = π r 4 8 η L ​

Resistance is inversely proportional to the fourth power of the radius ( r 4 r^4 r 4 ). In a full-term neonate with a normal subglottic tracheal diameter of 4.0 mm ( r = 2.0 mm r = 2.0\text{ mm} r = 2.0 mm ), just 1.0 mm of circumferential mucosal edema reduces the luminal diameter to 2.0 mm ( r = 1.0 mm r = 1.0\text{ mm} r = 1.0 mm ):

R edema R normal = 2.0 4 1.0 4 = 16 \frac{R_{\text{edema}}}{R_{\text{normal}}} = \frac{2.0^4}{1.0^4} = 16 R normal ​ R edema ​ ​ = 1. 0 4 2. 0 4 ​ = 16

A 1.0 mm rim of inflammatory edema increases airway resistance by 16-fold (1600%) and reduces the cross-sectional airway area by 75% . Hence, gentle airway instrumentation, avoidance of oversized uncuffed tubes, and maintaining cuff leak pressures below 20 cmH 2 O 20\text{ cmH}_2\text{O} 20 cmH 2 ​ O are essential to prevent post-extubation subglottic stenosis.

Thoracic Mechanics and Diaphragmatic Muscle Fatigue

Compliant Chest Wall: The neonatal rib cage is composed of pliable hyaline cartilage with ribs aligned horizontally. The chest wall has exceptionally high compliance , providing negligible outward recoil to counter inward pulmonary elastance.

Low Lung Compliance: The neonatal lung has low compliance due to immature alveolar septation, smaller alveolar diameters, and an underdeveloped elastic fiber matrix.

Paradoxical Inward Retraction: When inspiratory effort increases against resistance, the high negative intrapleural pressure pulls the compliant, cartilaginous thoracic cage inward (paradoxical sternal and intercostal indrawing), collapsing lung volume and decreasing effective tidal volume.

Diaphragmatic Muscle Fiber Composition: The diaphragm is the primary muscle of inspiration in neonates. However, the neonatal diaphragm is deficient in Type I (slow-twitch, oxidative, fatigue-resistant) muscle fibers:

  • Preterm neonates: ~10% Type I fibers
  • Term neonates: 20% to 25% Type I fibers
  • Adults: 50% to 55% Type I fibers

Intercostal muscles: < 15 % < 15\% < 15% Type I fibers in infants.

Under conditions of increased airway resistance or increased ventilatory workload, neonates quickly deplete their limited glycogen and oxidative stores, leading to rapid diaphragmatic fatigue , hypoventilation, respiratory acidosis, and apnea.

Gas Exchange and Rapid Desaturation

High Basal Oxygen Consumption: Neonatal resting O 2 \text{O}_2 O 2 ​ consumption is 6 to 8 mL/kg/min , more than twice the adult baseline of 3 to 4 mL/kg/min , driven by high metabolic demands for growth, brain metabolism, and thermogenesis.

Alveolar Ventilation to FRC Ratio: Neonatal alveolar ventilation ( V A V_A V A ​ ) is roughly 100 to 150 mL/kg/min, while FRC is small (~25 to 30 mL/kg). Consequently, the neonatal V A / FRC V_A/\text{FRC} V A ​ / FRC ratio is approximately 5:1 , compared to 1.5:1 in adults.

Pharmacokinetics of Inhalational Anaesthesia: The markedly elevated V A / FRC V_A/\text{FRC} V A ​ / FRC ratio, combined with lower blood-gas solubility of volatile anaesthetics in neonatal blood (decreased albumin and cholesterol levels), drives an extraordinarily rapid washin ( F A / F I F_A/F_I F A ​ / F I ​ equilibration) of volatile agents into the alveoli and blood. Inhalational induction is swift, as is emergence. However, volatile agent overdose and myocardial depression occur with equal speed.

Catastrophic Desaturation: The combination of an elevated metabolic consumption (6-8 mL/kg/min) and a small, unstable FRC reservoir leaves the neonate with minimal oxygen reserve during periods of hypoventilation or apnea. Critical hypoxaemia can develop within 15 to 30 seconds of tracheal occlusion or apnea.

  • 3. Fluid Compartments and Developmental Pharmacokinetics
  • Body Fluid Partitioning

Total Body Water (TBW): In premature infants, TBW accounts for 80% to 85% of body weight; in full-term neonates, TBW represents 75% to 80% , compared to 60% in adults.

Extracellular Fluid (ECF) Volume: The extracellular fluid compartment constitutes 40% of body weight in full-term neonates, compared to 20% in mature adults.

Volume of Distribution ( V d V_d V d ​ ) for Hydrophilic Drugs: Because hydrophilic, water-soluble drugs distribute into the expanded ECF space, neonates require substantially higher weight-based loading doses to achieve target plasma concentrations at receptor sites. [ High Total Body Water (75-80%) & ECF (40%) ]

  • |
  • Expanded Volume of Distribution (Vd)
  • |
  • Higher Initial Loading Doses Required (mg/kg)
  • Succinylcholine: 2.0-3.0 mg/kg IV (vs 1.0 mg/kg in adults)
  • Hydrophilic Antibiotics: Higher mg/kg doses

Clinical Dosing of Succinylcholine: The required intravenous intubating dose of succinylcholine in neonates and infants is 2.0 to 3.0 mg/kg (and up to 4.0 mg/kg intramuscularly), whereas 1.0 to 1.5 mg/kg is sufficient in adults. Despite this higher dose requirement, plasma pseudocholinesterase concentrations are 50% lower in neonates; the enlarged volume of distribution overrides this reduced enzymatic clearance.

Hepatic Drug Clearance and Metabolic Immaturity

Phase I Cytochrome P450 Systems: Most hepatic CYP450 isoenzymes (including CYP3A4, CYP1A2, and CYP2C9) display < 30 % < 30\% < 30% to 50% of adult activity at birth, maturing progressively over the first 6 to 12 months.

Phase II Conjugation Deficits: Glucuronidation pathways are severely underdeveloped in neonates. For example, morphine is metabolized into morphine-3-glucuronide (M3G) and active morphine-6-glucuronide (M6G) via UDP-glucuronosyltransferase (UGT2B7). Impaired glucuronidation in neonates prolongs the elimination half-life of morphine to 6 to 9 hours (compared to 1.5 to 2 hours in adults), increasing the risk of opioid accumulation, prolonged sedation, and postoperative apnea. Conversely, hepatic sulfation pathways are functional at birth, allowing neonates to safely eliminate paracetamol via sulfoconjugation.

Plasma Protein Binding: Circulating concentrations of both albumin (which binds acidic drugs such as thiopental and phenytoin) and alpha-1 acid glycoprotein (which binds basic drugs such as lidocaine, bupivacaine and many opioids) are markedly diminished in neonates. Furthermore, circulating maternal steroids and bilirubin displace drugs from binding sites. Consequently, the free, pharmacologically active unbound fraction of anaesthetic agents is elevated, increasing drug sensitivity and lowering toxicity thresholds.

Renal Maturation and Fluid Balance

Glomerular Filtration Rate (GFR): At birth, normal full-term GFR is only 20 to 30 mL/min/1.73 m 2 \text{m}^2 m 2 (approximately 25% of adult values). GFR increases to 50% of adult levels by 1 month of age and reaches full adult values (100-120 mL/min/1.73 m 2 \text{m}^2 m 2 ) by 1 to 2 years .

Tubular Immaturity and Salt Wasting: Neonatal renal tubules display low responsiveness to aldosterone and antidiuretic hormone (ADH), alongside an immature sodium-potassium ATPase pump. Neonates have low fractional sodium reabsorption and are obligate sodium losers . Administering sodium-free fluids (e.g. 5% dextrose in water without electrolytes) rapidly precipitates severe hyponatremia and cerebral edema.

Urine Concentrating Defect: Due to short Henle loops, low medullary tonicity, and low urea deposition in the renal pyramids, maximum neonatal urine osmolality is limited to 600 to 700 mOsm/kg (compared to 1200 mOsm/kg in adults). While urine diluting capacity is relatively preserved, the immature kidney cannot excrete large volume loads rapidly. Neonates have a narrow margin of fluid tolerance, making them susceptible to both dehydration and volume overload; all intravenous fluids must be administered via microbore tubing and infusion pumps.